Skip to main content Accessibility help
×
Home

Public health psychopharmacology: a new research discipline comes of age?

  • C. Barbui (a1), G. Ostuzzi (a1) and B. Godman (a2) (a3) (a4)

Abstract

Research evidence guiding the identification of pragmatic and effective actions aimed at improving the selection, availability, affordability and rational prescribing of medicines for mental disorders is sparse and inconsistent. In order to boost the development of new research, in this commentary we suggest to organise and classify all the activities in this area under a common theoretical framework and nomenclature, adopting the term ‘public health psychopharmacology’. Public health psychopharmacology is proposed as a research discipline, based on contributions from the fields of regulatory science, health services research and implementation science. Implementing the term public health psychopharmacology may offer advantages, as the scientific community would be more focused on common goals and objectives, with, likely, an increasing body of research evidence of practical use.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Public health psychopharmacology: a new research discipline comes of age?
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Public health psychopharmacology: a new research discipline comes of age?
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Public health psychopharmacology: a new research discipline comes of age?
      Available formats
      ×

Copyright

Corresponding author

*Address for correspondence: Prof C. Barbui, Section of Psychiatry, University of Verona, Ospedale Policlinico GB Rossi, Piazzale L.A. Scuro, 10 – 37134 Verona, Italy. (Email: corrado.barbui@univr.it)

Footnotes

Hide All

This Section of Epidemiology and Psychiatric Sciences appears in each issue of the Journal to stress the role of the epidemiological approach to promote advances in the field of clinical psychopharmacology, with a particular attention to controversial findings. The ultimate aims are to help develop a more critical attitude towards the results of research studies published in the international literature, to promote original research projects with higher methodological standards, and to implement the most relevant results of research in every-day clinical practice. These contributions are written in house by the journal's editorial team or commissioned by the Section Editor (no more than 1000 words, short unstructured abstract, 4 key-words, one Table or Figure and up to ten references).

Corrado Barbui, Section Editor

Footnotes

References

Hide All
Barbui, C, Bighelli, I (2013 a). A new approach to psychiatric drug approval in Europe. PLoS Medicine 10, e1001530.
Barbui, C, Bighelli, I (2013 b). Regulatory science in Europe: the case of schizophrenia trials. Lancet 382, 12341235.
Barbui, C, Dua, T, Kolappa, K, Saraceno, B, Saxena, S (2016). Access to psychotropic medicines in low-resource settings. Lancet Psychiatry 3, 913915.
Barbui, C, Dua, T, Kolappa, K, Saraceno, B, Saxena, S (2017 a). Mapping actions to improve access to medicines for mental disorders in low and middle income countries. Epidemiology and Psychiatric Sciences (in press).
Barbui, C, Addis, A, Amato, L, Traversa, G, Garattini, S (2017 b). Can systematic reviews contribute to regulatory decisions? European Journal of Clinical Pharmacology 73, 507509.
Garattini, S, Bertelè, V (2007). Non-inferiority trials are unethical because they disregard patients’ interests. Lancet 370, 18751877.
Garattini, S, Chalmers, I (2009). Patients and the public deserve big changes in evaluation of drugs. BMJ 338, b1025.
Geddes, J, Freemantle, N, Harrison, P, Bebbington, P (2000). Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 321, 13711376.
Hassan, L, Senior, J, Webb, RT, Frisher, M, Tully, MP, While, D, Shaw, JJ (2016). Prevalence and appropriateness of psychotropic medication prescribing in a nationally representative cross-sectional survey of male and female prisoners in England. BMC Psychiatry 16, 346.
Jaracz, J, Tetera-Rudnicka, E, Kujath, D, Raczynska, A, Stoszek, S, Czernas, W, Wierzbinski, P, Moniakowski, A, Jaracz, K, Rybakowski, J (2014). The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland. Pharmacological Reports 66, 613617.
Osterberg, L, Blaschke, T (2005). Adherence to medication. New England Journal of Medicine 353, 487497.
Ostuzzi, G, Papola, D, Gastaldon, C, Barbui, C (2017). New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base. Epidemiology and Psychiatric Sciences 26, 231233.
Woerkom, M, Piepenbrink, H, Godman, B, Metz, J, Campbell, S, Bennie, M (2012). Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications. Journal of Comparative Effectiveness Research 1, 527538.
World Health Organization (2003). Effective Medicines Regulation: Ensuring Safety, Efficacy and Quality. Retrieved from http://apps.who.int/medicinedocs/pdf/s4921e/s4921e.Pdf
World Health Organization (2015 a). Essential Medicines and Basic Health Technologies for Noncommunicable Diseases: Towards a Set of Actions to Improve Equitable Access in Member States. Retrieved from http://www.who.int/nmh/ncd-tools/targets/Final_medicines_and_technologies_02_07_2015.pdf
World Health Organization (2015 b). WHO Guideline on Country Pharmaceutical Pricing Policies. Retrieved from http://apps.who.int/medicinedocs/documents/s21016en/s21016en.pdf

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed